02.18.22
Galderma, the world’s largest independent dermatology company, announced today that Karen L. Ling will join its Advisory Committee, effective March 1.
Ling has a proven track record in executive roles at American International Group, Inc. (AIG), Allergan, Merck and Wyeth, guiding compensation, culture and program strategies that greatly improved shareholder relations and attracted and retained competitive talent.
“I am very pleased to welcome Ms. Ling to Galderma,” said Thomas Ebeling, chairman, Advisory Committee. “She brings to Galderma’s Advisory Committee her extensive expertise in the area of human resources management, having led the human capital function at major multinational companies. She also has wide experience in mergers and acquisitions, leading seamless integrations and unifying multiple acquisitions under a shared mission and brand.”
She is an accomplished global human resources executive with more than 25 years of pharmaceutical industry experience.
Ling recently retired from her role as executive vice president and chief human resources officer of AIG. In this position, she oversaw all aspects of human capital management, including talent development, talent acquisition, compensation and benefits, and diversity, equity and inclusion. As executive vice president and chief human resources officer at Allergan, Ling unified multiple, successive acquisitions. She was also instrumental in various innovative compensation programs for the executive leadership team, focused on increasing shareholder value.
Ling currently sits on the Board of Directors and Compensation Committee of iRhythm Technologies and on the Board of Directors and is chair of the Compensation Committee of TherapeuticsMD. In addition, she sits on the boards of two nonprofit organizations, ExpandED and the JED Foundation. Ling holds a juris doctor from the Boston University School of Law and earned her undergraduate degree from Yale University.